医学
血液恶性肿瘤
造血干细胞移植
呼吸系统
呼吸道感染
血液病
免疫学
病毒
造血干细胞
恶性肿瘤
血液恶性肿瘤
疾病
内科学
干细胞
造血
生物
遗传学
作者
Fareed Khawaja,Roy F. Chemaly
出处
期刊:Haematologica
[Ferrata Storti Foundation]
日期:2019-06-20
卷期号:104 (7): 1322-1331
被引量:41
标识
DOI:10.3324/haematol.2018.215152
摘要
In the USA and other western nations, respiratory syncytial virus is one of the most commonly encountered respiratory viruses among patients who have been diagnosed with a hematologic malignancy or who have undergone a stem cell transplant. Multiple studies have been performed to evaluate the complications associated with respiratory syncytial virus infections. Other studies have evaluated therapeutic agents and strategies in which these agents can be used. There have also been numerous reports of outbreaks in bone marrow transplant units and oncology wards, where infection control measures have been invaluable in controlling the spread of disease. However, despite these novel approaches, respiratory syncytial virus continues to be potentially fatal in immunocompromised populations. In this review, we discuss the incidence of respiratory syncytial viral infections, risk factors associated with progression from upper respiratory tract infection to lower respiratory tract infection, other complications and outcomes (including mortality), management strategies, and prevention strategies in patients with a hematologic malignancy and in hematopoietic cell transplant recipients.
科研通智能强力驱动
Strongly Powered by AbleSci AI